Cargando…

Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa

BACKGROUND: The HIV-1 epidemic in sub-Saharan Africa is heterogeneous with diverse unevenly distributed subtypes and regional differences in prevalence. Subtype-specific differences in disease progression rate and transmission efficiency have been reported, but the underlying biological mechanisms h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farinre, Omotayo, Gounder, Kamini, Reddy, Tarylee, Tongo, Marcel, Hare, Jonathan, Chaplin, Beth, Gilmour, Jill, Kanki, Phyllis, Mann, Jaclyn K., Ndung’u, Thumbi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097975/ https://www.ncbi.nlm.nih.gov/pubmed/33952315 http://dx.doi.org/10.1186/s12977-021-00554-4

Ejemplares similares

High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection
por: Gounder, Kamini, et al.
Publicado: (2015)

Partial compartmentalisation of HIV-1 subtype C between lymph nodes, peripheral blood mononuclear cells and plasma
por: Jeewanraj, Neschika, et al.
Publicado: (2023)

Corrigendum to “Partial compartmentalisation of HIV-1 subtype C between lymph nodes, peripheral blood mononuclear cells and plasma” [Virology 582 (2023) 62–70]
por: Jeewanraj, Neschika, et al.
Publicado: (2023)

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses
por: Luthuli, Bonisile, et al.
Publicado: (2023)

The Fitness Landscape of HIV-1 Gag: Advanced Modeling Approaches and Validation of Model Predictions by In Vitro Testing
por: Mann, Jaclyn K., et al.
Publicado: (2014)

HIV-1 vaccine immunogen design strategies
por: Mann, Jaclyn K, et al.
Publicado: (2015)

The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19
por: Mann, Jaclyn Kelly, et al.
Publicado: (2020)

No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial
por: Chopera, Denis R., et al.
Publicado: (2013)

Genetic determinants of Nef-mediated CD4 and HLA class I down-regulation differences between HIV-1 subtypes B and C
por: Mann, Jaclyn K., et al.
Publicado: (2015)

Dual HLA B*42 and B*81-reactive T cell receptors recognize more diverse HIV-1 Gag escape variants
por: Ogunshola, Funsho, et al.
Publicado: (2018)

Gag drug resistance mutations in HIV-1 subtype C patients, failing a protease inhibitor inclusive treatment regimen, with detectable lopinavir levels
por: Kelly Pillay, Sameshnee, et al.
Publicado: (2014)

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
por: Wright, JK, et al.
Publicado: (2009)

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
por: Naicker, Delon, et al.
Publicado: (2023)

The KT Jeang retrovirology prize 2023: Thumbi Ndung’u
por: Ndung’u, Thumbi
Publicado: (2023)

Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection
por: Mandizvo, Tawanda, et al.
Publicado: (2022)

Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles
por: Moyano, Ana, et al.
Publicado: (2023)

A20 Deep sequencing reveals viral evolution in GAG within protective HLA Alleles B*57: 02, B*58: 01, and B*7 supertype individuals acutely infected with HIV-1 subtype C in Durban, South Africa
por: Gounder, K, et al.
Publicado: (2018)

A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome
por: Hassan, Amin S, et al.
Publicado: (2021)

HIV-1 DNA sequence diversity and evolution during acute subtype C infection
por: Lee, Guinevere Q., et al.
Publicado: (2019)

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
por: Sutherland, Katherine A., et al.
Publicado: (2015)

Prevalence and seasonality of common viral respiratory pathogens, including Cytomegalovirus in children, between 0–5 years of age in KwaZulu-Natal, an HIV endemic province in South Africa
por: Famoroti, Temitayo, et al.
Publicado: (2018)

Dynamics and frequency of Gag transmitted polymorphisms in Zambia
por: Schaefer, M, et al.
Publicado: (2012)

Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave
por: Snyman, Jumari, et al.
Publicado: (2021)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

COVID-19 in Africa: preexisting immunity and HIV
por: Snyman, Jumari, et al.
Publicado: (2021)

Hen egg white bovine colostrum supplement reduces symptoms of mild/moderate COVID-19: a randomized control trial
por: Mann, Jaclyn Kelly, et al.
Publicado: (2023)

Human Immunodeficiency Virus gag and protease: partners in resistance
por: Fun, Axel, et al.
Publicado: (2012)

S04-06 OA. Polyvalent Gag-specific CD8 T-cells with enhanced functional properties are enriched in HIV-1 clade C infected individuals with lower viral loads
por: Julg, B, et al.
Publicado: (2009)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

Modelling and in vitro testing of the HIV-1 Nef fitness landscape
por: Barton, John P, et al.
Publicado: (2019)

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics
por: Rolland, Morgane, et al.
Publicado: (2010)

African-led health research and capacity building- is it working?
por: Kasprowicz, Victoria O., et al.
Publicado: (2020)

Knowledge of HIV Serodiscordance, Transmission, and Prevention among Couples in Durban, South Africa
por: Kilembe, William, et al.
Publicado: (2015)

Implementation of couples’ voluntary HIV counseling and testing services in Durban, South Africa
por: Kilembe, William, et al.
Publicado: (2015)

Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria
por: Rawizza, Holly E., et al.
Publicado: (2013)

Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients
por: Mlimi, Hlelolwenkosi, et al.
Publicado: (2022)

Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa
por: Hölzemer, Angelique, et al.
Publicado: (2015)

New insights into retroviral Gag–Gag and Gag–membrane interactions
por: Maldonado, José O., et al.
Publicado: (2014)

Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria
por: Meloni, Seema Thakore, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_deeqmn7n7838aeb83oef9gl741